Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 7,717-7,728 of 10,592
Drug study icon
CompletedNCT02881177

Oxytocin HIV Meth Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Addiction
Drug study icon
CompletedNCT01573273

Oxytocin in Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT02568709

Oxytocin MEG Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Drug study icon
WithdrawnNCT03865615

Oxytocin on Approach Bias and Craving

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 40 Years
Countries
United States
Sponsor
Jennifer Mitchell
Condition
Addiction
Drug study icon
CompletedNCT01012167

Oxytocin or Galantamine Versus Placebo for Negative Symptoms and Cognitive Impairments in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT04523922

Oxytocin to Enhance Integrated Treatment for AUD and PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSD, AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
PTSD, Addiction
Drug study icon
CompletedNCT04228289

Oxytocin to Treat PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Drug study icon
WithdrawnNCT03636555

Oxytocin Treatment for Alcohol Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Addiction
Drug study icon
CompletedNCT01028677

Oxytocin Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.